What Makes Cara Therapeutics So Intriguing?

Published: Mar 17, 2017

There's a significant need for new pain relievers that don't pose the risk of addiction, and Cara Therapeutics (NASDAQ:CARA) has multiple studies with data on tap that could prove it has developed a better approach to addressing pain than existing medication.

A flurry of activity

The company is working on CR845, a drug that tackles pain differently than opioids like oxycodone and fentanyl.

Back to news